GENMAB A/S - SPONSORED ADS (GMAB)

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / SPONSORED ADS
Total 13F shares
61,630,004
Share change
-1,992,571
Total reported value
$1,890,191,241
Put/Call ratio
17%
Price per share
$30.67
Number of holders
244
Value change
-$39,717,699
Number of buys
156
Number of sells
88

Institutional Holders of GENMAB A/S - SPONSORED ADS (GMAB) as of Q3 2025

As of 30 Sep 2025, GENMAB A/S - SPONSORED ADS (GMAB) was held by 244 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 61,630,004 shares. The largest 10 holders included Orbis Allan Gray Ltd, ALLIANCEBERNSTEIN L.P., Paradigm Biocapital Advisors LP, ARROWSTREET CAPITAL, LIMITED PARTNERSHIP, HARDING LOEVNER LP, BlackRock, Inc., RENAISSANCE TECHNOLOGIES LLC, FIRST TRUST ADVISORS LP, MORGAN STANLEY, and TWO SIGMA ADVISERS, LP. This page lists 244 institutional shareholders reporting positions in this security for the Q3 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.